The Pharmacokinetics and Colonic Tissue Concentrations of Cyclosporine After IV, Oral, and Enema Administration
- 1 January 1991
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 31 (1) , 76-80
- https://doi.org/10.1002/j.1552-4604.1991.tb01890.x
Abstract
This study compares pharmacokinetic parameters and colonic tissue concentrations of cyclosporine administered by olive‐oil or water‐retention enemas with conventional intravenous (IV) and oral dosing. Five medical students were enrolled in a prospective crossover study. All subjects received a single dose of cyclosporine on four separate occasions, once orally, once as an olive‐oil enema, once as a water enema, and once IV. Cyclosporine concentration was measured in blood and in colonic tissue obtained by flexible sigmoidoscopy. Bioavailability was 18 ± 7% (mean ± SDJ for the oral dose and was unmeasurable for the oil and water enemas. The concentration of cyclosporine in colon tissue was 32,443 ± 17,251 ng/g (mean ± SDJ for the IV dose, 2797 ± 1812 ng/g for the oral dose, 21,727 ± 14,090 ng/g for the oil enema, and 25,318 ± 30,408 ng/g for the water enema. The authors conclude that the bioavailability of cyclosporine, and thus the systemic absorption after administration by a retention enema, is negligible. The colonic tissue concentration of cyclosporine after IV or rectal administration via an enema is tenfold higher than that for oral dosing. These findings suggest that cyclosporine‐retention enemas produce high distal colonic tissue concentrations with negligible systemic absorption after a single dose in healthy subjects and should be evaluated as treatment for patients with left‐sided colitis. Because cyclosporine administered by the IV route provided sharply higher colonic tissue concentrations than those seen with oral therapy, pulse IV cyclosporine should be tried for patients with severe ileitis and colitis.Keywords
This publication has 18 references indexed in Scilit:
- Cyclosporin for Crohn's diseaseAlimentary Pharmacology & Therapeutics, 2007
- Low-dose cyclosporin for Crohn's disease: implications for clinical trialsAlimentary Pharmacology & Therapeutics, 2007
- A Placebo-Controlled, Double-Blind, Randomized Trial of Cyclosporine Therapy in Active Chronic Crohn's DiseaseNew England Journal of Medicine, 1989
- TREATMENT OF CHRONIC PROCTOSIGMOIDITIS WITH CYCLOSPORIN ENEMASThe Lancet, 1989
- TREATMENT OF REFRACTORY ULCERATIVE COLITIS WITH CYCLOSPORIN ENEMASThe Lancet, 1989
- Treatment of Crohn's disease in relapse with cyclosporin ABritish Journal of Surgery, 1988
- Clinical Pharmacokinetics of CyclosporinClinical Pharmacokinetics, 1986
- Side effects of systemic cyclosporine in patients not undergoing transplantationThe American Journal of Medicine, 1984
- CYCLOSPORIN A TISSUE LEVELS IN A CADAVERIC RENAL ALLOGRAFT RECIPIENTTransplantation, 1983
- DISTRIBUTION AND PERSISTENCE OF CYCLOSPORIN IN HUMAN TISSUESThe Lancet, 1982